Search Results - "Castleden, S."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
  2. 2

    Individual Nuclei Differ in Their Sensitivity to the Cytoplasmic Inducers of DNA Synthesis: Implications for the Origin of Cell Cycle Variability by Hola, M., Howard, M., Nawaz, F.N., Castleden, S., Brooks, R.F.

    Published in Experimental cell research (15-12-1996)
    “…Nuclei of multinucleate cells generally initiate DNA synthesis simultaneously, suggesting that the timing of DNA synthesis depends upon the appearance of a…”
    Get full text
    Journal Article
  3. 3

    Initiation of DNA synthesis by nuclei from scrape-ruptured quiescent mammalian cells in high-speed supernatants of Xenopus egg extracts by Hola, M, Castleden, S, Howard, M, Brooks, R F

    Published in Journal of cell science (01-11-1994)
    “…Demembranated sperm heads, detergent-isolated somatic nuclei and even naked DNA are efficiently replicated in cytoplasmic extracts of activated amphibian eggs,…”
    Get full text
    Journal Article
  4. 4

    A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model by Castleden, S A, Chong, H, Garcia-Ribas, I, Melcher, A A, Hutchinson, G, Roberts, B, Hart, I R, Vile, R G

    Published in Human gene therapy (20-11-1997)
    “…The herpes simplex virus-thymidine kinase/ganciclovir (HSVtk/GCV) system produces both direct and immune-mediated tumor cell killing. Here, we compare the…”
    Get more information
    Journal Article
  5. 5

    Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression by Vile, Richard G., Castleden, Simon, Marshall, John, Camplejohn, Richard, Upton, Carol, Chong, Heung

    Published in International journal of cancer (10-04-1997)
    “…Direct delivery of the herpes simplex virus thymidine kinase (HSVtk) gene, in combination with the prodrug ganciclovir (GC), has been used for the treatment of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component by VILE, R. G, NELSON, J. A, CASTLEDEN, S, HEUNG CHONG, HART, I. R

    Published in Cancer research (Chicago, Ill.) (01-12-1994)
    “…Previously we have demonstrated safe and effective transfer of the HSVtk cytotoxic gene to primary murine melanoma tumors by direct injection of plasmid and…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Retroviral vectors : From laboratory tools to molecular medicines by VILE, R. G, TUSZYNSKI, A, CASTLEDEN, S

    Published in Molecular biotechnology (01-04-1996)
    “…The majority of clinical trials for gene therapy currently employ retroviral-mediated gene delivery. This is because the life cycle of the retrovirus is well…”
    Get full text
    Journal Article
  10. 10

    Retroviral vectors. From laboratory tools to molecular medicine by Vile, R G, Tuszynski, A, Castleden, S

    Published in Molecular biotechnology (01-04-1996)
    “…The majority of clinical trials for gene therapy currently employ retroviral-mediated gene delivery. This is because the life cycle of the retrovirus is well…”
    Get full text
    Journal Article
  11. 11

    37 Combination gene therapies for the treatment of malignant melanoma in vivo by Vilea, R., Chong, Heung, Diaz, R.M., Hart, I., Castleden, S., Tuszynski, A.

    Published in European journal of cancer (1990) (01-11-1995)
    “…For in vivo gene delivery, we have used the murine tyrosinase promoter to restrict expression of genes to melanoma cells. These genes are aimed either at…”
    Get full text
    Journal Article
  12. 12